EXPLANATORY NOTE
This Amendment No. 3 (this “Amendment”) amends and supplements the Schedule 13D filed with the Securities and Exchange Commission (the “SEC”) on February 14, 2022, as amended by Amendment No. 1 thereto filed with the SEC on March 7, 2022 and Amendment No. 2 thereto filed with the SEC on June 2, 2022 (collectively, the “Schedule 13D”), by the Reporting Persons relating to shares of common stock, par value $0.0001 per share (“Common Stock”), of Flotek Industries, Inc. (the “Issuer”).
Information reported in the Schedule 13D remains in effect except to the extent that it is amended, restated or superseded by information contained in this Amendment. Capitalized terms used but not defined this Amendment have the respective meanings set forth in the Schedule 13D.
Item 3. | Source and Amount of Funds or Other Consideration. |
Item 3 of the Schedule 13D is hereby amended to include the following:
The source of funds for the purchase of the Prefunded Warrants (as defined below) was working capital of ProFrac Holdings II, LLC (“ProFrac Holdings II”).
Item 4. | Purpose of Transaction. |
Item 4 of the Schedule 13D is hereby amended to include the following:
June 2022 Securities Purchase Agreement
On June 17, 2022, the Issuer entered into a Securities Purchase Agreement (the “June 2022 Securities Purchase Agreement”) with ProFrac Holdings II. Pursuant to the June 2022 Securities Purchase Agreement, (i) ProFrac Holdings II paid to the Issuer $19,500,000 in cash and (ii) ProFrac Holdings II received prefunded warrants (the “Prefunded Warrants”) permitting ProFrac Holdings II to purchase 13,104,839 shares of the Issuer’s Common Stock at an exercise price equal to $0.0001 per share. ProFrac Holdings II and its affiliates may not receive any voting or consent rights in respect of the Prefunded Warrants or the underlying shares of the Issuer’s Common Stock unless and until (i) the Issuer has obtained approval from a majority of its shareholders excluding ProFrac Holdings II and its affiliates and (ii) ProFrac Holdings II has paid an additional $4,500,000 to the Issuer; provided, however, that ProFrac Holdings II may exercise the Prefunded Warrants immediately prior to the sale of the shares of the Issuer’s Common Stock subject to such exercise to a non-affiliate of ProFrac Holdings II. The closing of the transactions contemplated under the June 2022 Securities Purchase Agreement took place on June 21, 2022.
Registration Rights Agreement Amendment
On June 21, 2022, concurrent with the closing of the transactions contemplated under the June 2022 Securities Purchase Agreement, the Issuer, ProFrac Holdings II and ProFrac Holdings, LLC (“ProFrac Holdings”) entered into an amendment (the “Registration Rights Agreement Amendment”) to the Registration Rights Agreement between the Issuer and ProFrac Holdings dated as of May 17, 2022 (the “Registration Rights Agreement”). The Registration Rights Agreement Amendment provides for, among other things, (i) the joinder of ProFrac Holdings II to the Registration Rights Agreement and (ii) the registration of the shares of the Issuer’s Common Stock issuable to ProFrac Holdings II upon exercise the Prefunded Warrants.
The foregoing descriptions of the June 2022 Securities Purchase Agreement, the Prefunded Warrants and the Registration Rights Agreement Amendment do not purport to be complete and are qualified in their entirety by reference to the complete text of the June 2022 Securities Purchase Agreement, the Form of Prefunded Warrants and the Registration Rights Agreement Amendment, which are filed as Exhibits 1 through 3 to this Amendment, respectively, and are incorporated herein by reference.
Board Designation
Under the Master Transaction Agreement between ProFrac Holdings and the Issuer, dated as of February 2, 2022, ProFrac Holdings was granted the right to designate two designees to serve on the Issuer’s board of directors (the “Issuer’s Board”). On May 17, 2022, in connection with the closing of a Securities Purchase Agreement, ProFrac Holdings was granted the right to designate two additional members of the Issuer’s Board, for a total of four out of seven directors on the Issuer’s Board. As of the date of this Amendment, (i) Matt D. Wilks, the Executive Chairman of ProFrac Holding Corp. (“PubCo”), has been designated as one of these designees and was elected to the Issuer’s Board at the Issuer’s 2022 annual meeting of shareholders held on June 9, 2022, (ii) PubCo and the Issuer are in discussions regarding a second potential designee, and (iii) the remaining designations have not yet been made.
Page 5